| B01AF02 |
Apixaban |
ELIQUIS |
Film coated tablet |
2.5 |
mg |
20 |
Bristol-Myers Squibb/Pfizer EEIG, Обединено Кралство |
10 |
mg |
46.01 |
4.532 |
22.66 |
100% |
|
Съгласно РУ |
КЦРР-2413/22.02.2013 г.; НСР-2498/24.01.2014; НСР-4899/22.10.2014; НСР-9295/05.05.2016; НСР-9829/21.07.2016; НСР-9979/18.08.2016 |
02.01.2017 |
|
Активен |
3265 |
| B01AX05 |
Fondaparinux sodium |
B01AX05 Fondaparinux sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B01AX05 |
Fondaparinux |
Arixtra |
Solution for injection |
7.5 mg/0.6 ml |
|
10 pre-filled syringe (glass) / with an automatic safety / system |
Aspen Pharma Trading Limited, Ирландия |
2.5 |
mg |
251.82 |
7.694 |
230.82 |
100% |
|
Съгласно РУ |
НСР-2884/05.03.2014; НСР-4932/22.10.2014; НСР-9711/07.07.2016; НСР-12146/27.03.2017 г. |
02.05.2017 |
08.09.2012 |
Активен |
3283 |
| B01AX05 |
Fondaparinux |
Arixtra |
Solution for injection |
2,5 mg/0,5 ml |
|
10 pre-filled syringe (glass) / with an automatic safety / system |
Aspen Pharma Trading Limited, Ирландия |
2.5 |
mg |
76.94 |
7.694 |
76.94 |
100% |
|
Съгласно РУ |
HCР-254/25.06.2013; НСР-3116/26.03.2014; НСР-5653/18.02.2015.; НСР-7596/26.11.2015. |
02.01.2016 |
|
Активен |
1366 |
| B01AX05 |
Fondaparinux |
Arixtra |
Solution for injection |
2,5 mg/0,5 ml |
|
10 pre-filled syringe (glass) / with an automatic safety / system |
Aspen Pharma Trading Limited, Ирландия |
2.5 |
mg |
76.94 |
7.692 |
76.92 |
100% |
|
Съгласно РУ |
КЦРР-1315/21.08.2012 г.; HCР-253/25.06.2013. |
02.08.2013 |
|
Заличен |
1366 |
| B02AA03 |
Aminomethylbenzoic acid |
B02AA03 Aminomethylbenzoic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02AA03 |
Aminomethylbenzoic acid |
Pambenzacid |
Solution for injection |
50 |
mg |
10 |
Софарма АД, България |
100 |
mg |
16.18 |
3.236 |
16.18 |
100% |
|
Съгласно РУ |
№40/27.08.2009; НСР-12173/27.03.2017 |
02.05.2017 |
08.09.2012 |
Заличен |
170 |
| B02BA01 |
Phytomenadione |
B02BA01 Phytomenadione |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BA01 |
Phytomenadion |
Konakion MM |
Solution for injection |
10 |
mg |
5 |
Рош България ЕООД, България |
20 |
mg |
3.97 |
1.588 |
3.97 |
100% |
|
Съгласно РУ |
№ 24/31.07.2009; КЦРР-623/18.05.2013 и КП-193/24.04.2013; НСР-3824/16.06.2014 |
16.07.2014 |
08.09.2012 |
Активен |
2956 |
| B02BB01 |
Human fibrinogen |
B02BB01 Human fibrinogen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BB01 |
Human fibrinogen |
Haemocomplettan P |
Powder for solution for injection/infusion |
1 |
g |
1 |
CSL Behring GmbH, Германия |
5 |
g |
713.18 |
3565.8999 |
713.18 |
100% |
|
Съгласно РУ |
№ 110/ 11.10.2010; КП-10/16.01.2015 и НСР-2989/12.03.2014 |
02.02.2015 |
08.09.2012 |
Активен |
3502 |
| B02BD01 |
coagulation factor IX, II, VII and X in combination |
B02BD01 coagulation factor IX, II, VII and X in combination |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BD01 |
Human Prothrombin Complex |
OCTAPLEX |
Powder and solvent for solution for injection |
500 |
IU |
1 |
Octapharma (IP) Ltd., Обединено Кралство |
350 |
IU |
498.35 |
250.22221 |
357.82 |
100% |
|
Съгласно РУ |
№ 162/ 20.04.2011; НСР-5135/27.11.2014; НСР-8227/22.02.2016 |
02.04.2016 |
08.09.2012 |
Активен |
3417 |
| B02BD01 |
Coagulation factor IX, II, VII and X in combination |
Prothromplex Total NF |
Powder and solvent for solution for injection |
600 |
IU |
1 |
Baxalta Innovations GmbH, Австрия |
350 |
IU |
427.88 |
250.22221 |
427.88 |
100% |
|
Съгласно РУ |
№ 190/ 22.08.2011; НСР-3271/14.04.2014 |
02.11.2016 |
08.09.2012 |
Активен |
2753 |
| B02BD01 |
Coagulation factor IX, II, VII and X in combination |
Uman complex powd. Inf. Vial 500 IU + solv. Vial 20 ml + inf. Set |
Solution for infusion |
500 |
IU |
1 |
Kedrion S.p.A., Италия |
350 |
IU |
307.82 |
215.25874 |
307.82 |
100% |
|
Съгласно РУ |
НСР-1935/27.11.2013 и КП-4/15.01.2015; НСР-5645/13.02.2015 (допуска предварително изпълнение) |
16.02.2015 |
08.09.2012 |
Заличен |
3500 |
| B02BD02 |
Human coagulation factor VIII |
B02BD02 Human coagulation factor VIII |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| B02BD02 |
Human coagulation factor VIII |
Beriate |
Powder and solvent for solution for injection/infusion |
1000 |
IU |
1 |
CSL Behring GmbH, Германия |
500 |
IU |
905.34 |
308.70999 |
617.42 |
100% |
|
Съгласно РУ |
НСР-6760/23.07.2015 |
16.08.2015 |
|
Активен |
4047 |
| B02BD02 |
Human coagulation factor VIII |
Beriate |
Powder and solvent for solution for injection/infusion |
500 |
IU |
1 |
CSL Behring GmbH, Германия |
500 |
IU |
420.37 |
308.70999 |
308.71 |
100% |
|
Съгласно РУ |
НСР-6760/23.07.2015 |
16.08.2015 |
|
Активен |
4046 |
| B02BD02 |
Human coagulation factor VIII |
Beriate |
Powder and solvent for solution for injection/infusion |
250 |
IU |
1 |
CSL Behring GmbH, Германия |
500 |
IU |
236.72 |
308.70999 |
154.36 |
100% |
|
Съгласно РУ |
НСР-6760/23.07.2015 |
16.08.2015 |
|
Активен |
4045 |
| B02BD02 |
Human coagulation factor VIII |
EMOCLOT 500 IU |
Powder and solvent for solution for infusion |
500 |
IU |
1 |
Kedrion S.p.A., Италия |
500 |
IU |
316.18 |
308.70999 |
308.71 |
100% |
|
Съгласно РУ |
№ 163/ 20.01.2011.; НСР-7927/28.01.2016. |
02.03.2016 |
08.09.2012 |
Заличен |
368 |
| B02BD02 |
Human coagulation factor VIII |
Fanhdi |
Powder and solvent for solution for injection |
1000 |
IU |
1 |
Instituto Grifols, S.A., Испания |
500 |
IU |
790.64 |
308.70999 |
617.42 |
100% |
|
Съгласно РУ |
№ 70/ 19.04.2010; № 255/ 04.11.2011; протокол №16/04.07.2013. |
02.09.2014 |
08.09.2012 |
Активен |
904 |
| B02BD02 |
Human coagulation factor VIII |
Fanhdi |
Powder and solvent for solution for injection |
500 |
IU |
1 |
Instituto Grifols, S.A., Испания |
500 |
IU |
401.32 |
308.70999 |
308.71 |
100% |
|
Съгласно РУ |
№ 70/ 19.04.2010; № 255/ 04.11.2011; протокол №16/04.07.2013. |
02.09.2014 |
08.09.2012 |
Активен |
903 |
| B02BD02 |
Human coagulation factor VIII |
Fanhdi |
Powder and solvent for solution for injection |
250 |
IU |
1 |
Instituto Grifols, S.A., Испания |
500 |
IU |
201.13 |
308.70999 |
154.36 |
100% |
|
Съгласно РУ |
№ 70/ 19.04.2010; № 255/ 04.11.2011; протокол №16/04.07.2013. |
02.09.2014 |
08.09.2012 |
Активен |
902 |
| B02BD02 |
Human coagulation factor VIII |
Haemoctin |
Powder and solvent for solution for injection |
1000 |
IU |
1 |
Biotest Pharma GmbH, Германия |
500 |
IU |
808.64 |
308.70999 |
617.42 |
100% |
|
Съгласно РУ |
КЦРР-819/15.06.2012 г.; HCР-263/28.06.2013; НСР-5168/27.11.2014 |
16.12.2014 |
08.09.2012 |
Заличен |
1924 |
| B02BD02 |
Human coagulation factor VIII |
Haemoctin |
Powder and solvent for solution for injection |
500 |
IU |
1 |
Biotest Pharma GmbH, Германия |
500 |
IU |
410.33 |
308.70999 |
308.71 |
100% |
|
Съгласно РУ |
КЦРР-819/15.06.2012 г.; HCР-264/28.06.2013; НСР-5167/27.11.2014 |
16.12.2014 |
08.09.2012 |
Заличен |
1923 |